Search

Your search keyword '"Cosio, Borja"' showing total 533 results

Search Constraints

Start Over You searched for: Author "Cosio, Borja" Remove constraint Author: "Cosio, Borja"
533 results on '"Cosio, Borja"'

Search Results

1. Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers

2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

3. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

4. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

5. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

6. Lung-function trajectories: relevance and implementation in clinical practice

7. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

9. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

10. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

11. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

13. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

15. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

19. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist

20. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

25. Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.

26. AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.

32. AERIFY-1/-2: 2 phase 3 randomised controlled trials of itepekimab in former smokers with moderate-to-severe COPD

33. Lung-function trajectories: relevance and implementation in clinical practice

35. Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

36. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

39. Real-world biologics response and super-response in the International Severe Asthma Registry cohort

40. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

41. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

42. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort

43. Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort

44. Sex differences between women and men with COPD: A new analysis of the 3CIA study

47. International Severe Asthma Registry: Mission Statement

48. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD

49. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

Catalog

Books, media, physical & digital resources